Great Bay Bio Ecosystem Goes Global and Gains Spotlight at BIO International Convention 2024

▲BIO International Convention 2024

Dr. Liang Chen, CEO and co-founder of Great Bay Bio, attended the conference with his team, gathering with old and new friends to jointly discuss achievements and cooperation opportunities in antibody drug discovery, molecular design, and the process development and production of large-molecule drugs in pharmaceutical R&D. Moreover,Dr. Chen Liang's public presentation of the GBB ecosystem at a roundtable conference hosted by Hong Kong Science and Technology Parks Corporation ignited a buzz, attracting numerous attendees for exchanges and collaborations.

▲Global First Look at GBB's Ecosystem

▲GBB Ecosystem Goes Viral

The ecosystem forms a perfect closed loop composed of multiple innovative technology platforms.Including intelligent targeted integration cell line construction platform (AlfaCell), intelligent non-selection culture medium optimization platform (AlfaOPA), biopharmaceutical molecule design and optimization platform (AlfaDAX), and antibody sequence generation platform (AlfaBodY),Providing strong momentum for drug discovery and CMC development, reducing costs and improving efficiency, helping customers develop products faster and better.

▲GBB Ecosystem Composition

The BIO International Convention 2024, founded by the Biotechnology Innovation Organization (BIO) in 1993, is the world's largest, most professional, and most influential biotechnology event. It provides a comprehensive platform for information exchange, technology cooperation and transactions, and venture capital financing through specialized forums, press conferences, networking sessions, matchmaking meetings, and other activities.